Spain’s competition authority, CNMC, has published a report on the Royal Decree to Regulate the Financing and Price Setting of Medicine and Sanitary Products. The new regulation presented by the Ministry of Health, seeks to regulate two crucial aspects of medication and medical supplies: financing by the National Health Service (SNS) and the prices of each.
The document sets several categories for medical supplies “which may be included as pharmacy supplies within the SNS for out-patient use”. implying that the price of these supplies would be regulated and set by law, while also being subsidised by public finances.
Among the biggest criticisms presented in the CNMC’s report (available in full here) are those against the requirement for said products to be distributed only “by a technician capable of performing the act of distribution.” The report argues that “distribution and supply of these products should be allowed in establishments” other than pharmacies. The report condemns these limitations as “unjustified restriction of activity”.
“Although exceptional cases may justify it in a specific moment, the vast majority (cotton, gauze, bandages, stool absorbers and excreta cleansers, etc.) do not require specialized personel to handle them.”
Source: OK Diario
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
New UK Legislation to Combat Ticket Resale and Algorithmic Price-Fixing
Jan 12, 2025 by
CPI
Supreme Court Justices Grill TikTok’s Lawyer in National Security Case
Jan 12, 2025 by
CPI
FTC, DOJ Weigh Antitrust Issues in Musk’s OpenAI Case
Jan 12, 2025 by
CPI
UK Trial Begins as Apple Defends App Store Fees in £1.5 Billion Case
Jan 12, 2025 by
CPI
Italy to Retain Full Control of Data in Potential Deal with Musk’s Starlink
Jan 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand